Therapeutic Group: Drugs of Nervous System Presentation Migrex 200 mg tablet: Each tablet contains Tolfenamic acid BP 200 mg. Description Tolfenamic acid (N-(2-methyl-3-chlorophenyl) anthranilic acid) belongs to the fenamate group and is a potent inhibitor of cyclo-oxygenase enzyme, thus inhibits the synthesis of important inflammatory mediators such as thromboxane (Tx) B2 and prostaglandin (PG) E2. […]
Therapeutic Group: Disease-modifying Antirheumatic Presentation Tofacent 5: Each tablet contains Tofacitinib Citrate INN equivalent to Tofacitinib 5 mg Tofacent XR 11: Each Extended Release tablet contains Tofacitinib Citrate INN equivalent to Tofacitinib 11 mg Description Tofacitinib is a Janus kinase (JAK) inhibitor. JAKs are intracellular enzymes which transmit signals arising from cytokine or growth factor-receptor […]
Therapeutic Group: Disease-modifying Antirheumatic Presentation Tolosa 80 solution for IV infusion: Each vial contains Tocilizumab INN 80 mg in 4 ml solution for IV infusion. Description Tocilizumab is a recombinant humanized anti-human interleukin 6 (IL-6) receptor monoclonal antibody of the immunoglobulin IgG1κ (gamma 1, kappa) subclass with a typical H2L2 polypeptide structure. Each light chain […]
Therapeutic Group: Aminoglycoside Antibiotic Presentation Intobac nebuliser solution: Each ampoule contains 5 ml solution for inhalation of Tobramycin USP 300 mg. Description Tobramycin nebuliser solution is a sterile, clear, slightly yellow, non-pyrogenic, aqueous solution with the pH and salinity adjusted specifically for the administration by a nebuliser. Tobramycin is an aminoglycoside antibiotic and acts primarily […]
Therapeutic Group: Opthalmic-Anti-Allergic Presentation Intobac 0.3% eye drops: Each ml contains Tobramycin USP 3 mg. Description Intobac is a broad-spectrum, aminoglycoside antibiotic of bacteriocidal type of action. It works by inhibition of bacterial protein synthesis by binding to the 30S subunit of the bacterial ribosome. Indications Intobac eye drops is a topical antibiotic indicated in […]
Therapeutic Group: Anti Bacterial Presentation Each vial contains Tigecycline INN 50 mg as lyophilized powder for IV infusion Description Tigecycline is a glycylcycline antibacterial agent for intravenous infusion. Tigecycline inhibits protein translation in bacteria by binding to the 30S ribosomal subunit and blocking the entry of amino-acyl tRNA molecules into the A site of the […]
Therapeutic Group: Anti Bacterial Presentation Tigacil: Each vial contains Tigecycline INN 50 mg as lyophilized powder. Description Tigecycline is a glycylcycline antibacterial agent for intravenous infusion. Tigecycline inhibits protein translation in bacteria by binding to the 30S ribosomal subunit and blocking entry of amino-acyl tRNA molecules into the A site of the ribosome. This prevents […]
Therapeutic Group: Anti Spasmodic Presentation Timozin tablet: Each film coated tablet contains Tiemonium Methylsulfate INN 50 mg. Timozin IV/IM injection: Each 2ml contains Tiemonium Methylsulfate INN 5 mg. Description Timozin (Tiemonium methylsulfate) is a synthetic antispasmodic drug with mixed musculotropic and anticholinergic activity Indications Timozin is an antispasmodic drug. It reduces muscle spasms of the […]
Therapeutic Group: Cardiovascular Presentation Ticarel 60: Each tablet contains Ticagrelor INN 60 mg. Ticarel 90: Each tablet contains Ticagrelor INN 90 mg. Description Ticagrelor, a cyclopentyltriazolopyrimidine which is a reversible platelet aggregation inhibitor. Ticagrelor reversibly binds with the platelet P2Y12 adenosine diphosphate (ADP) receptor and thereby inhibits signal transduction and platelet aggregation. Indications Acute Coronary […]
Therapeutic Group: Bone and Joint Disorder Presentation Ubilon : Each tablet contains Tibolone INN 2.5 mg. Description Tibolone is a synthetic steroid with tissue specific estrogenic, progestogenic and androgenic effect. Following oral administration tibolone is rapidly metabolized into three compounds, which contribute to the pharmacological effects of tibolone. Two of these metabolites (3 alpha-hydroxide-tibolone and […]